Jesse Mendelsohn, executive vice president at Model N, discusses how selling drugs directly to patients differs from traditional government programs.Pharmaceutical Executive: What impact will TrumpRx and other DTC programs have on drug availability?Jesse Mendelsohn: To be clear, anything that expands access to pharmaceutical manufacturing and drugs is good. Even if this only gets several thousand […]
